Class of diabetes drugs may be linked to increased risk of IBD
Diabetes patients taking dipeptidyl peptidase-4 inhibitors (DPP-4), commonly known as gliptins, may have an increased risk of also developing inflammatory bowel disease, warn Canadian researchers.
Source: Nursing Times - Category: Nursing Source Type: news